401 North Washington Street
About Emmes CorporationWe collaborate with our clients to produce valued, trusted scientific research. Our team members at Emmes are passionate about making a difference in the quality of human health, and we have supported more than a thousand studies across a diverse range of diseases since our formation in 1977.
CEO: Anne Lindblad
CFO: Brian Hochheimer
CMO: Robert Lindblad
COO: Paul Van Veldhuisen
Please click here for Emmes job opportunities.
20 articles with Emmes Corporation
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced its contribution to a study for the National Institute on Drug Abuse Clinical Trials Network and a related article published in the New England Journal of Medicine.
Emmes Employees Contribute to New England Journal of Medicine Report on Pregnant Women with Epilepsy
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the company's involvement in a recent article published in the New England Journal of Medicine.
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that long-time employee, Dr. Paul VanVeldhuisen, has been named President of Emmes Public Sector.
Emmes announced that the Montgomery County Chamber of Commerce has selected Emmes as the recipient of its 2020 Corporate Achievement Award.
Emmes announced that Jonathan DeCarlo has been promoted to chief financial officer.
Emmes announced that three corporate vice presidents have been promoted. Dr. Traci Clemons has been named chief research officer, Marian Ewell is now chief scientific innovation officer, and Jennifer Hester is the company's chief human resources officer.
Emmes announced that it was selected as one of the best places to work in the greater Washington area.
Emmes today announced that its data and statistical analysis work for the Adaptive COVID-19 Treatment Trial (ACTT) played an important role in the accelerated timetable to evaluate remdesivir's effectiveness in treating hospitalized CO
Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area. The ranking is compiled annually by the Washington Business Journal.
Emmes today announced that Dr. Joe Sliman has been named the company's chief medical officer (CMO). According to Dr. Anne Lindblad , president and chief operating officer, "The depth and breadth of
Emmes announced that Heather Hill, Dr. Adam Mendizabal and Dr. Nilay Shah have been promoted to vice president.
Emmes today announced that Kathleen Wolf has joined the company as vice president of clinical operations. She has two decades of leadership experience in the biopharmaceutical industry, including most recently as a senior director with AstraZeneca's MedImmune unit.
Emmes Will Support Development of a New Universal Flu Vaccine for The National Institute of Allergy and Infectious Diseases
The Company's Contract with Digital Infuzion Adds New Dimension to its Long NIAID History
The Company is Hiring Additional Staff to Support its Awards Totaling Over $9 Million
Company Offices in Rockville, Frederick and Tysons Corner Allow Employees to Choose a Location Closest to Home
Emmes announced that Behrman Capital, a leading private equity firm, has made a significant investment in the company.
Company Also Recognized by the Alliance for Workplace Excellence and Ranked as the Area's Fifth Largest Biosciences Employer
The Emmes Corporation Release: New Research Links Umbilical Cord Blood to Motor Function Improvement in Children with Cerebral Palsy
The research demonstrated improvements in motor function a year after the injection of a high dose of stem cells from a child's own cord blood.